US58933Y1055
US58933Y1055
Merck & Company, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 65.011.000.000 | 64.168.000.000 | 1.3% |
| Cost of Revenue | 16.382.000.000 | 15.193.000.000 | 7.8% |
| Gross Profit | 48.629.000.000 | 48.975.000.000 | 0.7% |
| 26.522.000.000 | 28.754.000.000 | 7.8% | |
| Operating Income | 22.107.000.000 | 20.221.000.000 | 9.3% |
| Pretax Income | 21.067.000.000 | 19.936.000.000 | 5.7% |
| Net Income Common Stockholders | 18.254.000.000 | 17.117.000.000 | 6.6% |
| -- | -- | -- | |
| -- | -- | -- |